Price To Earnings Ratio 17.97 | Sector PE 70.08 |
PB Ratio 4.26 | Sector PB 9.24 |
EPS 77.56 | Dividend Yield 1.00 |
Today's Volume 1.891 M | 5 Day Avg. Volume 814.236 K |
PEG Ratio 0.18 | Market Cap. ₹ 24,640.00 Cr. |
Time | NATCOPHARM | VS | Industry |
---|---|---|---|
1 Day | 3.16% | 0.81% | |
1 Week | 3.44% | 3.5% | |
1 Month | 1.68% | 3.78% | |
6 Months | 31.38% | 21.84% | |
1 Year | 86.93% | 48.38% |
Period (Days) | SMA | Indication |
---|---|---|
10 | 1365.2 | Bullish |
20 | 1386.27 | Bullish |
30 | 1374.26 | Bullish |
50 | 1392.04 | Bullish |
100 | 1409.01 | Bearish |
200 | 1219.46 | Bullish |
Annual | FY 2024 | FY 2023 | FY 2022 | FY 2021 | |||||
---|---|---|---|---|---|---|---|---|---|
Operating Activities | 1211.60 | 849.10 | 46.50 | 298.80 | |||||
Investing Activities | -1032.70 | -477.10 | -5.30 | -103.30 | |||||
Financing Activities | -246.90 | -363.00 | 34.80 | -185.70 | |||||
Net Cash Flow | -68.00 | 9.00 | 76.00 | 9.80 |
All Figures in ₹ Cr., unless mentioned otherwise
Name | 1D (%) | 1W (%) | 1M (%) | 6M (%) | 1Y (%) |
---|---|---|---|---|---|
NATCO Pharma | 3.16 | 3.44 | 1.68 | 31.38 | 86.93 |
Alembic | 3.08 | 7.1 | 7.09 | 1.53 | 1.53 |
Aurobindo Pharma | -0.48 | 1.34 | -10.97 | -5.1 | 14.47 |
Fortis Healthcare | 2.61 | -3.07 | 9.52 | 36.48 | 79.71 |
Ajanta Pharmaceuticals | -0.58 | 0.06 | 0.06 | 13.87 | 47.58 |
Natco Pharma Limited is a vertically integrated R&D pharmaceutical company based in India. The company's field of activity is the pharmaceutical business, which includes research and development, production and sale of bulk drugs and ready-made medical preparations. The company produces ready-to-use dosage forms (FDFs), which it sells in India, the US and the rest of the world, and also produces active pharmaceutical ingredients (APIs). Its capabilities include multi-step synthesis, semi-synthetic splicing technologies, production of potent APIs and peptides. The company operates in two segments: Pharmaceuticals and Agricultural Chemicals. In the pharmaceutical industry, the Company channels its sales through FDFs and APIs. The agrochemicals segment focuses on specialty products, including pest control.